Customs, VAT and Importer Obligations for Devices in Thailand
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
Q: What customs duties and taxes apply when importing medical devices into Thailand?
1. Key takeaways
Most medical devices entering Thailand face zero import tariff. In addition, a China-ASEAN Free Trade Area certificate of origin, Form E, can secure more preferential treatment. At the import stage a 7% value added tax (VAT) is payable. The specific tariff rate is subject to the Thai Customs tariff schedule in force and to HS code classification, so the same product may attract different rates depending on how it is classified, which makes HS code consistency critical in clearance and is also one of the common causes of LPI delay. On the tax side, the core principle is that VAT is accrued where the business activity takes place, which in practice means in Thailand, and this links the tax architecture directly to the licence-holding structure.
- Tariffs are mostly zero. Most medical devices carry a zero import tariff, with the exact rate determined by the Thai Customs tariff schedule and HS classification.
- Form E can improve treatment. The China-ASEAN Free Trade Area certificate of origin secures more preferential treatment.
- VAT of 7% applies at import. Importation attracts a 7% value added tax.
- VAT is accrued in Thailand. Where business activity occurs in Thailand, payment should be completed in Thailand; this is the core of Thai tax compliance.
- Importers carry record obligations. Import and sales records kept for no less than five years, valid import/establishment licence and GDPMD maintained, correct labelling before distribution, and scientific documentation of quality, standards, performance and safety retained for inspection.
- Wireless devices need NBTC approval. Devices with Bluetooth, Wi-Fi, cellular or RFID functions require NBTC approval completed before import, as an independent second gate alongside the Thai FDA.
2. Legal basis
The customs treatment rests on the Thai Customs tariff schedule, under which most medical devices bear zero import tariff, with specific rates always subject to the current schedule and to HS code classification. The China-ASEAN Free Trade Area certificate of origin, Form E, provides the basis for more preferential treatment, and a 7% VAT applies at the import stage. On the tax principle, VAT is accrued on economic activity within Thailand: the compliant path is that the Thai distributor pays the licence holder, VAT is accrued and paid in Thailand, and the licence holder then remits to the manufacturer under a compliant agreement. Any arrangement in which the distributor pays an offshore licence-holding entity, or in which funds bypass Thailand, conflicts with this principle and carries tax risk. The importer’s record obligations comprise three items: keeping import and sales records for no less than five years; maintaining a valid import or establishment licence together with GDPMD; and ensuring that products are correctly labelled before distribution, while retaining the scientific documentation of quality, standards, performance and safety for registered products available for inspection. At clearance, four points govern: the LPI is a precondition without which customs will not release the goods; HS codes must be consistent across filings; the declared value should not fluctuate significantly between shipments; and a single shipment must not mix products with expired and valid certificates, since partial clearance is usually not allowed.
3. Expert insights
The single most consequential idea in this area is that the question of where VAT is accrued and the question of whether holding, importing and collecting payment sit with the same entity are, in Thailand, the same question. If business activity takes place in Thailand, payment should be completed in Thailand, so the compliant fund flow runs from the Thai distributor to the licence holder, through VAT accrual and payment in Thailand, and then out to the manufacturer under a compliant agreement. Structures that let the distributor pay an offshore certificate-holding entity, or that route funds around Thailand entirely, do not merely look untidy; they conflict with the accrual principle and create tax risk on top of the regulatory exposure already discussed. Designing the tax architecture separately from the licensing architecture therefore produces a double exposure, regulatory and tax, from a single structural decision. Wireless connectivity adds a second dimension: devices containing Bluetooth, Wi-Fi, cellular or RFID functions need NBTC approval, and that approval must be completed before import. The NBTC gate is independent of the Thai FDA, but the two procedures can be advanced in parallel, so the planning task is to sequence the NBTC application early enough that it does not become the critical path after registration is complete.
4. Practical recommendations
- Evaluate VAT accrual and entity structure together. Treat the question of where VAT is accrued and the question of whether holding, import and collection sit with one entity as a single design decision; splitting them creates dual exposure.
- Follow the compliant fund flow. Distributor pays the licence holder, VAT is accrued and paid in Thailand, and the licence holder remits to the manufacturer under a compliant agreement.
- Use Form E where available. Prepare the China-ASEAN Free Trade Area certificate of origin to secure more preferential treatment.
- Lock HS code consistency. Keep classifications consistent across filings, since inconsistency is a common cause of LPI delay and can change the applicable tariff.
- Keep the importer record set complete. Import and sales records for no less than five years, valid licence and GDPMD, correct labelling before distribution, and the quality, standard, performance and safety scientific documentation retained for inspection.
- Start NBTC approval before import. For devices with Bluetooth, Wi-Fi, cellular or RFID functions, complete NBTC approval before importation, running it in parallel with the Thai FDA procedures.
5. Verification checklist
- □ Thai Customs tariff schedule (most medical devices zero tariff, subject to HS classification)
- □ China-ASEAN Free Trade Area certificate of origin Form E
- □ 7% VAT at the import stage
- □ Importer record obligations (import and sales records kept at least five years; establishment licence and GDPMD maintained; correct labelling before distribution; quality, standard, performance and safety scientific documents retained)
- □ LPI as the precondition for customs release
- □ NBTC approval completed before import
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Thailand. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the Thai FDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us